Trucketet et al. [14] have demonstrated that activated platelets can stimulate endothelial cells and dermal FBs to produce a pro-fibrotic mediator, thymic stromal lymphopoietin (TSLP), in an IL-1β dependent manner in patients with SSc. The gene discussed is TSLP; the disease is systemic sclerosis.